AR050290A1 - 2-{-3,2-(fenil)-oxazol-4-ilmetoxil-ciclohexilmetoxi} derivados del acido propionico como ligandos de receptores ppar - Google Patents
2-{-3,2-(fenil)-oxazol-4-ilmetoxil-ciclohexilmetoxi} derivados del acido propionico como ligandos de receptores pparInfo
- Publication number
- AR050290A1 AR050290A1 ARP050103351A ARP050103351A AR050290A1 AR 050290 A1 AR050290 A1 AR 050290A1 AR P050103351 A ARP050103351 A AR P050103351A AR P050103351 A ARP050103351 A AR P050103351A AR 050290 A1 AR050290 A1 AR 050290A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- derivatives
- phenyl
- ilmetoxil
- ciclohexilmetoxi
- Prior art date
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- 235000019260 propionic acid Nutrition 0.000 title 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Composiciones farmacéuticas que los contienen, métodos de preparacion y usos para tratar hiperlipidemia y diabetes. Reivindicacion 1: Un compuesto de formula (1), en la cual los significados son: R1 es H, alquilo (C1-6); R2 es H, O-alquilo (C1-3), CF3; o R1 y R2 junto con el anillo de fenilo, forman un naftilo condensado; R3 es alquilo (C1-6); R4 es alquilo (C1-6), bencilo; R5 es H, alquilo (C1-6); y las sales fisiologicamente tolerables, solvatos y derivados fisiologicamente funcionales del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039532A DE102004039532B4 (de) | 2004-08-14 | 2004-08-14 | Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050290A1 true AR050290A1 (es) | 2006-10-11 |
Family
ID=35159900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103351A AR050290A1 (es) | 2004-08-14 | 2005-08-11 | 2-{-3,2-(fenil)-oxazol-4-ilmetoxil-ciclohexilmetoxi} derivados del acido propionico como ligandos de receptores ppar |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7956077B2 (es) |
| EP (1) | EP1778655B1 (es) |
| JP (1) | JP2008509891A (es) |
| KR (1) | KR20070040813A (es) |
| CN (1) | CN101031553A (es) |
| AR (1) | AR050290A1 (es) |
| AT (1) | ATE430739T1 (es) |
| AU (1) | AU2005274492A1 (es) |
| BR (1) | BRPI0513999A (es) |
| CA (1) | CA2576545A1 (es) |
| DE (2) | DE102004039532B4 (es) |
| DK (1) | DK1778655T3 (es) |
| ES (1) | ES2326423T3 (es) |
| IL (1) | IL181010A0 (es) |
| MX (1) | MX2007000913A (es) |
| PE (1) | PE20060624A1 (es) |
| PT (1) | PT1778655E (es) |
| SV (1) | SV2006002191A (es) |
| TW (1) | TW200619211A (es) |
| UY (1) | UY29063A1 (es) |
| WO (1) | WO2006018115A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100915108B1 (ko) * | 2001-08-31 | 2009-09-03 | 사노피-아벤티스 도이칠란트 게엠베하 | Ｐｐａｒ-활성화제로서의 디아릴사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물 |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039532A patent/DE102004039532B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 DE DE502005007249T patent/DE502005007249D1/de active Active
- 2005-07-30 KR KR1020077003581A patent/KR20070040813A/ko not_active Application Discontinuation
- 2005-07-30 EP EP05772240A patent/EP1778655B1/de not_active Not-in-force
- 2005-07-30 ES ES05772240T patent/ES2326423T3/es active Active
- 2005-07-30 AU AU2005274492A patent/AU2005274492A1/en not_active Abandoned
- 2005-07-30 JP JP2007525215A patent/JP2008509891A/ja not_active Abandoned
- 2005-07-30 AT AT05772240T patent/ATE430739T1/de not_active IP Right Cessation
- 2005-07-30 MX MX2007000913A patent/MX2007000913A/es not_active Application Discontinuation
- 2005-07-30 DK DK05772240T patent/DK1778655T3/da active
- 2005-07-30 PT PT05772240T patent/PT1778655E/pt unknown
- 2005-07-30 CA CA002576545A patent/CA2576545A1/en not_active Abandoned
- 2005-07-30 CN CNA2005800271498A patent/CN101031553A/zh active Pending
- 2005-07-30 WO PCT/EP2005/008281 patent/WO2006018115A1/de active Application Filing
- 2005-07-30 BR BRPI0513999-6A patent/BRPI0513999A/pt not_active IP Right Cessation
- 2005-08-09 SV SV2005002191A patent/SV2006002191A/es unknown
- 2005-08-10 PE PE2005000924A patent/PE20060624A1/es not_active Application Discontinuation
- 2005-08-11 AR ARP050103351A patent/AR050290A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127242A patent/TW200619211A/zh unknown
- 2005-08-12 UY UY29063A patent/UY29063A1/es unknown
-
2007
- 2007-01-28 IL IL181010A patent/IL181010A0/en unknown
- 2007-02-06 US US11/671,673 patent/US7956077B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7956077B2 (en) | 2011-06-07 |
| CA2576545A1 (en) | 2006-02-23 |
| EP1778655B1 (de) | 2009-05-06 |
| TW200619211A (en) | 2006-06-16 |
| PT1778655E (pt) | 2009-07-13 |
| PE20060624A1 (es) | 2006-07-27 |
| BRPI0513999A (pt) | 2008-05-20 |
| JP2008509891A (ja) | 2008-04-03 |
| US20070197613A1 (en) | 2007-08-23 |
| AU2005274492A1 (en) | 2006-02-23 |
| EP1778655A1 (de) | 2007-05-02 |
| WO2006018115A1 (de) | 2006-02-23 |
| MX2007000913A (es) | 2007-04-16 |
| SV2006002191A (es) | 2006-07-07 |
| DE102004039532B4 (de) | 2006-09-21 |
| DE102004039532A1 (de) | 2006-03-02 |
| DE502005007249D1 (de) | 2009-06-18 |
| UY29063A1 (es) | 2006-02-24 |
| ATE430739T1 (de) | 2009-05-15 |
| IL181010A0 (en) | 2007-07-04 |
| DK1778655T3 (da) | 2009-08-24 |
| KR20070040813A (ko) | 2007-04-17 |
| CN101031553A (zh) | 2007-09-05 |
| ES2326423T3 (es) | 2009-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6382155A2 (es) | Agonistas del receptor gpr120 de arilo y usos de los mismos | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| CY1108908T1 (el) | Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4 | |
| EA201001585A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| AR063022A1 (es) | Derivados de indol antagonistas del receptor de glucagon, composiciones farmaceuticas que los contienen y usos para tratar diabetes mellitus tipo 2 y estados patologicos relacionados. | |
| AR049577A1 (es) | Derivados de hidantoina, procesos para su preparacion, composiciones y su uso | |
| PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
| PE20141540A1 (es) | Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2 | |
| HK1165954A1 (en) | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors | |
| AR049291A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| PE20100256A1 (es) | Compuestos de ester boronato y composiciones farmaceuticas de los mismos | |
| AR054508A1 (es) | Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla | |
| PE20061348A1 (es) | DERIVADOS DEL ACIDO PIRMIDINCARBOXILICO COMO MODULADORES DE PPAR-alfa | |
| CO6260069A2 (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
| PE20080834A1 (es) | Derivados de eter diarilico antagonistas de receptores opioides | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| PE20060657A1 (es) | Derivados de pirimidina como moduladores de ppar-alfa | |
| AR077960A1 (es) | Derivados de benzamida n-sustituidos como inhibidores del transportador de glicina 1 (glyt-1) | |
| PE20061446A1 (es) | Compuestos de bencimidazol-carboxamida como agonistas de receptores 5-ht4 | |
| ECSP088257A (es) | Derivados de amida | |
| AR074353A1 (es) | Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatititis atopica. | |
| PE20050292A1 (es) | Derivados de acido alcanoico sustituidos con aril-cicloalquilo, procedimientos para su obtencion y su empleo como medicamentos | |
| EA200700364A1 (ru) | Производные амида кинуреновой кислоты как антагонисты nr2b подтипа рецептора nmda |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |